Via Medical News Today, another step forward in the ability of scientists to control stem cell differentiation: "Novocell researchers report in the article a differentiation process that successfully engineers human embryonic stem cells (hESCs) into endocrine cells capable of producing insulin as well as other pancreatic endocrine hormones ... The in vitro differentiation process mimics normal pancreatic development in the body. ... The efficient, reproducible production of human embryonic stem cell- derived, insulin-producing endocrine cells through a process that mirrors the development of human pancreatic cells represents a critical step toward providing a renewable source of cells for diabetes therapy. This provides a foundation upon which we can build a standardized process for generating functional insulin-producing cells for the treatment of diabetic patients." Full control of stem cell differentiation will mean replacement tissue on demand for any damaged part of the body.

View the Article Under Discussion: http://www.medicalnewstoday.com/medicalnews.php?newsid=54627
Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/